Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials
about
Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials.Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study.Long-Term Efficacy of Maintenance Therapy for Multiple Myeloma: A Quantitative Synthesis of 22 Randomized Controlled Trials.The Expression of Actin-Related Protein 2/3 Complex Subunit 5 (ARPC5) Expression in Multiple Myeloma and its Prognostic Significance
P2860
Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bortezomib-based vs non-bortez ...... I randomized controlled trials
@ast
Bortezomib-based vs non-bortez ...... I randomized controlled trials
@en
type
label
Bortezomib-based vs non-bortez ...... I randomized controlled trials
@ast
Bortezomib-based vs non-bortez ...... I randomized controlled trials
@en
prefLabel
Bortezomib-based vs non-bortez ...... I randomized controlled trials
@ast
Bortezomib-based vs non-bortez ...... I randomized controlled trials
@en
P2093
P2860
P356
P1476
Bortezomib-based vs non-bortez ...... I randomized controlled trials
@en
P2093
Colin K He
Liang Shao
Qing Liang
Shangqin Liu
Xiangyu Meng
Xiaoping Liu
P2860
P304
P356
10.2147/OTT.S84828
P407
P577
2015-06-15T00:00:00Z